| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation.
|
N Engl J Med
|
2014
|
4.00
|
|
2
|
High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas.
|
Eur J Endocrinol
|
2011
|
1.69
|
|
3
|
18F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature?
|
J Nucl Med
|
2009
|
1.57
|
|
4
|
Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.
|
J Clin Endocrinol Metab
|
2007
|
1.53
|
|
5
|
Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis.
|
Acta Neuropathol
|
2010
|
1.36
|
|
6
|
Congenital isolated adrenocorticotropin deficiency: an underestimated cause of neonatal death, explained by TPIT gene mutations.
|
J Clin Endocrinol Metab
|
2004
|
1.29
|
|
7
|
Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study.
|
J Clin Endocrinol Metab
|
2010
|
1.24
|
|
8
|
PROKR2 variants in multiple hypopituitarism with pituitary stalk interruption.
|
J Clin Endocrinol Metab
|
2012
|
1.19
|
|
9
|
Functional characterization of nonmetastatic paraganglioma and pheochromocytoma by (18) F-FDOPA PET: focus on missed lesions.
|
Clin Endocrinol (Oxf)
|
2013
|
1.08
|
|
10
|
A genome-wide approach reveals novel imprinted genes expressed in the human placenta.
|
Epigenetics
|
2012
|
1.08
|
|
11
|
Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications.
|
Endocr Relat Cancer
|
2009
|
1.03
|
|
12
|
Genetic screening of combined pituitary hormone deficiency: experience in 195 patients.
|
J Clin Endocrinol Metab
|
2006
|
1.02
|
|
13
|
Simultaneous hyper- and hypomethylation at imprinted loci in a subset of patients with GNAS epimutations underlies a complex and different mechanism of multilocus methylation defect in pseudohypoparathyroidism type 1b.
|
Hum Mutat
|
2013
|
1.00
|
|
14
|
Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism.
|
J Clin Endocrinol Metab
|
2013
|
0.96
|
|
15
|
A new specific succinate-glutamate metabolomic hallmark in SDHx-related paragangliomas.
|
PLoS One
|
2013
|
0.96
|
|
16
|
Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis.
|
Eur J Endocrinol
|
2013
|
0.94
|
|
17
|
Detection of genetic hypopituitarism in an adult population of idiopathic pituitary insufficiency patients with growth hormone deficiency.
|
Pituitary
|
2011
|
0.93
|
|
18
|
The analysis of quantitative expression of somatostatin and dopamine receptors in gastro-entero-pancreatic tumours opens new therapeutic strategies.
|
Eur J Endocrinol
|
2006
|
0.93
|
|
19
|
A potential inhibitory role for the new truncated variant of somatostatin receptor 5, sst5TMD4, in pituitary adenomas poorly responsive to somatostatin analogs.
|
J Clin Endocrinol Metab
|
2010
|
0.92
|
|
20
|
An uncommon phenotype with familial central hypogonadism caused by a novel PROP1 gene mutant truncated in the transactivation domain.
|
J Clin Endocrinol Metab
|
2005
|
0.91
|
|
21
|
Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort.
|
J Clin Endocrinol Metab
|
2014
|
0.90
|
|
22
|
Somatostatin receptor sst2 decreases cell viability and hormonal hypersecretion and reverses octreotide resistance of human pituitary adenomas.
|
Cancer Res
|
2008
|
0.87
|
|
23
|
Inactivation of transcription factor pit-1 to target tumoral somatolactotroph cells.
|
Hum Gene Ther
|
2012
|
0.87
|
|
24
|
Inactivation of PITX2 transcription factor induced apoptosis of gonadotroph tumoral cells.
|
Endocrinology
|
2011
|
0.86
|
|
25
|
McCune-Albright syndrome: a detailed pathological and genetic analysis of disease effects in an adult patient.
|
J Clin Endocrinol Metab
|
2014
|
0.84
|
|
26
|
Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations.
|
Endocr Relat Cancer
|
2013
|
0.83
|
|
27
|
First report of harlequin syndrome as the presenting feature of Carney Triad: a diagnostic and imaging challenge.
|
J Clin Oncol
|
2012
|
0.83
|
|
28
|
First report of bilateral pheochromocytoma in the clinical spectrum of HIF2A-related polycythemia-paraganglioma syndrome.
|
J Clin Endocrinol Metab
|
2013
|
0.83
|
|
29
|
A familial form of congenital hypopituitarism due to a PROP1 mutation in a large kindred: phenotypic and in vitro functional studies.
|
J Clin Endocrinol Metab
|
2004
|
0.82
|
|
30
|
Preoperative 18F-FDG uptake is strongly correlated with malignancy, Weiss score, and molecular markers of aggressiveness in adrenal cortical tumors.
|
World J Surg
|
2012
|
0.82
|
|
31
|
Deficit in anterior pituitary function and variable immune deficiency (DAVID) in children presenting with adrenocorticotropin deficiency and severe infections.
|
J Clin Endocrinol Metab
|
2011
|
0.81
|
|
32
|
Somatostatinergic ligands in dopamine-sensitive and -resistant prolactinomas.
|
Eur J Endocrinol
|
2008
|
0.80
|
|
33
|
Expression of somatostatin receptors, dopamine D₂ receptors, noradrenaline transporters, and vesicular monoamine transporters in 52 pheochromocytomas and paragangliomas.
|
Endocr Relat Cancer
|
2011
|
0.80
|
|
34
|
Should routine analysis of the MEN1 gene be performed in all patients with primary hyperparathyroidism under 40 years of age?
|
World J Surg
|
2010
|
0.79
|
|
35
|
Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study.
|
Hum Mol Genet
|
2013
|
0.79
|
|
36
|
Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds.
|
Endocr Relat Cancer
|
2012
|
0.79
|
|
37
|
Unilateral agenesis of internal carotid artery associated with congenital combined pituitary hormone deficiency and pituitary stalk interruption without HESX1, LHX4 or OTX2 mutation: a case report.
|
Pituitary
|
2012
|
0.79
|
|
38
|
RET genetic screening in patients with medullary thyroid cancer: the Moroccan experience.
|
J Cancer Res Ther
|
2009
|
0.78
|
|
39
|
Lentiviral vectors efficiently transduce human gonadotroph and somatotroph adenomas in vitro. Targeted expression of transgene by pituitary hormone promoters.
|
J Endocrinol
|
2004
|
0.78
|
|
40
|
Long-term control of a MEN1 prolactin secreting pituitary carcinoma after temozolomide treatment.
|
Ann Endocrinol (Paris)
|
2012
|
0.78
|
|
41
|
Ras and Rap1 govern spatiotemporal dynamic of activated ERK in pituitary living cells.
|
Cell Signal
|
2012
|
0.78
|
|
42
|
Gs alpha overexpression and loss of Gs alpha imprinting in human somatotroph adenomas: association with tumor size and response to pharmacologic treatment.
|
Int J Cancer
|
2007
|
0.78
|
|
43
|
Somatostatin receptor sst2 gene transfer in human prolactinomas in vitro: impact on sensitivity to dopamine, somatostatin and dopastatin, in the control of prolactin secretion.
|
Mol Cell Endocrinol
|
2012
|
0.77
|
|
44
|
Genetic causes of combined pituitary hormone deficiencies in humans.
|
Ann Endocrinol (Paris)
|
2012
|
0.77
|
|
45
|
Physiopathology of somatolactotroph cells: from transduction mechanisms to cotargeting therapy.
|
Ann N Y Acad Sci
|
2011
|
0.77
|
|
46
|
Combined treatment by octreotide and everolimus: Octreotide enhances inhibitory effect of everolimus in aggressive meningiomas.
|
J Neurooncol
|
2015
|
0.77
|
|
47
|
Ghrelin receptor (GHS-R1a) and its constitutive activity in somatotroph adenomas: a new co-targeting therapy using GHS-R1a inverse agonists and somatostatin analogs.
|
J Clin Endocrinol Metab
|
2014
|
0.76
|
|
48
|
Case seminar: a young female with acute hyponatremia and a sellar mass.
|
Endocrine
|
2011
|
0.75
|
|
49
|
The significance of MEN1 mutations in pituitary carcinomas.
|
Biomark Med
|
2013
|
0.75
|
|
50
|
Targeting dopamine receptors subtype 2 (D2DR) in pheochromocytomas: head-to-head comparison between in vitro and in vivo findings.
|
J Clin Endocrinol Metab
|
2013
|
0.75
|
|
51
|
Sinonasal paraganglioma with long-delayed recurrence and metastases: genetic and imaging findings.
|
J Clin Endocrinol Metab
|
2013
|
0.75
|
|
52
|
In vivo and in vitro evidence of somatostatin receptors expression in a dedifferentiated retroperitoneal liposarcoma.
|
Clin Nucl Med
|
2014
|
0.75
|
|
53
|
[Congenital hypopituitarism: when should transcription factor gene screenings be performed?].
|
Presse Med
|
2004
|
0.75
|
|
54
|
European guidance for the molecular diagnosis of pseudohypoparathyroidism not caused by point genetic variants at GNAS: an EQA study.
|
Eur J Hum Genet
|
2015
|
0.75
|
|
55
|
[Mechanisms of pituitary tumorigenesis].
|
Presse Med
|
2008
|
0.75
|
|
56
|
[Abstracts of the 30th Congress of the French Society of Endocrinology, 2013, Paris, France].
|
Ann Endocrinol (Paris)
|
2013
|
0.75
|